Gara Jalqabaatti › Skileeroosisii Baay'inaa Keessummaa
Qorannoo klinikaalii Skileeroosisii Baay'inaa Keessummaa Ameerikaa Keessatti hirmaatuu
Qorannoo 18 Skileeroosisii Baay'inaa Keessummaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- St. Louis, MOQorannoo 4
- Memphis, TNQorannoo 4
- Orlando, FLQorannoo 4
- Chicago, ILQorannoo 4
- Columbus, OHQorannoo 3
- Greenville, SCQorannoo 3
- Tampa, FLQorannoo 3
- Burbank, CAQorannoo 3
- Scottsdale, AZQorannoo 3
- Kansas City, KSQorannoo 3
Naannoon
- ArizonaQorannoo 4
- CaliforniaQorannoo 10
- FloridaQorannoo 4
- GeorgiaQorannoo 3
- IllinoisQorannoo 5
- KansasQorannoo 4
- MichiganQorannoo 4
- MissouriQorannoo 4
- North CarolinaQorannoo 3
- OhioQorannoo 6
- South CarolinaQorannoo 3
- TennesseeQorannoo 4
- TexasQorannoo 4
- WashingtonQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07067463Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03109288A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07299019A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07609719A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07840326Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07477639Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04047628A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT07225504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05359653Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT07139743Intermittent Hypoxia in Persons With Multiple Sclerosis
Namoota walitti qabaa jira
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT06276634A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 27-Gur-2026 · NCT06138132Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Namoota walitti qabaa jira
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 23-Gur-2026 · NCT06390930Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Gur-2026 · NCT07392879Home Based Functional Balance Intervention for Multiple Sclerosis
Namoota walitti qabaa jira
Umuriin 40 hanga 90 · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07355387"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Onk-2025 · NCT07222618Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
Namoota walitti qabaa jira
Umuriin 22 hanga 75 · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT05964829MS-ResearchBiomarkerS
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamooKaffaltii hirmaatootaaf ibsa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Gur-2024 · NCT05204459Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.